About us
Profile
Board of Directors
Scientific Directors
Our Science
Strategy
Activities and Technologies
Pipeline
Pipeline
Onco IX (PHC-102, Imaging)
68
Ga-OncoFAP (Imaging)
177
Lu-OncoFAP-23
OncoFAP-GlyPro-MMAE
OncoPSMA-GlyPro-MMAE
Press Release & Media
Press Releases
Events
Media Library
Work with us
Careers
Industrial Ph.D. Program
Partnering & Fee-For-Services
About us
Profile
Board of Directors
Scientific Directors
Our Science
Strategy
Activities and Technologies
Pipeline
Pipeline
Onco IX (PHC-102, Imaging)
68
Ga-OncoFAP (Imaging)
177
Lu-OncoFAP-23
OncoFAP-GlyPro-MMAE
OncoPSMA-GlyPro-MMAE
Press Release & Media
Press Releases
Events
Media Library
Work with us
Careers
Industrial Ph.D. Program
Partnering & Fee-For-Services
News & Events
Philogen S.p.A. announced that the European Commission (EC) has granted Orphan Drug Designation to L19TNF for the treatment of soft-tissue sarcoma.
PR Philogen 281016
Last News & Events
Nov
2022
13
Philogen to attend the TIDES Europe 2022 in Vienna, Austria (16-18 November)
Mar
2022
15
Philogen to attend the PEGS Europe 2022 on November 14-16, 2022
